首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1532486

球囊瓣膜成形术设备市场- 按产品类型（标准、切割、评分球囊）、应用（主动脉瓣狭窄、肺动脉瓣狭窄）、年龄组（儿科、成人）、最终用途（医院、ASC） - 全球预测（2024 年 -第2032章

Balloon Valvuloplasty Devices Market - By Product Type (Standard, Cutting, Scoring Balloon), Application (Aortic Valve Stenosis, Pulmonary Valve Stenosis), Age Group (Pediatric, Adult), End-use (Hospitals, ASCs) - Global Forecast (2024 - 2032)

出版日期: 2024年05月17日 | 出版商:

Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

简介目录

由于医疗保健支出的增加和医疗保健基础设施的进步，预计 2024 年至 2032 年全球球囊瓣膜成形术设备市场规模的复合年增长率将达到 4.8%。根据美国医学会的数据，2022 年美国医疗保健支出成长 4.1%，达到 4.5 兆美元，即人均 13,493 美元。这一增长支持了对先进治疗的更大投资，以改善心臟护理。

最近，由于医疗保健支出不断增加，大量资源被分配用于创新治疗，包括球囊瓣膜成形术。医疗保健设施的扩大和增强正在改善先进手术的取得。此外，对医疗基础设施的投资不断增加，支持了球囊瓣膜成形术设备的广泛使用，使其在治疗心臟瓣膜疾病方面更容易、更有效。

球囊瓣膜成形术设备市场按产品类型、应用、年龄层、最终用途和地区划分。

按产品类型划分，由于治疗狭窄心臟瓣膜的需求不断增加，切割球囊细分市场预计从 2024 年到 2032 年将以显着速度成长。与传统手术方法相比，这些设备提供了侵入性较小的选择，在改善心臟护理方面取得了重大进展。此外，配备锋利刀片的切割球囊可透过在瓣膜组织中进行精确切口，有助于扩大瓣膜并恢復正常血流，在治疗狭窄方面发挥重要作用。

由于为心臟病患者提供专门护理的需求不断增长，预计门诊手术中心最终用途部分的球囊瓣膜成形术设备行业将在 2024 年至 2032 年期间增长。这些中心使用球囊瓣膜成形术装置来治疗心臟瓣膜狭窄的患者。该技术可进行微创手术，以改善患者的治疗效果并缩短復原时间。透过将这些设备整合到他们的服务中，门诊手术中心确保他们处于心臟护理的最前沿，为患者提供更安全、更有效的治疗选择。

从地区来看，在人口老化和心血管手术扩张的推动下，欧洲球囊瓣膜成形术设备产业规模预计将在 2024 年至 2032 年间强劲成长。该地区的医疗保健提供者正在采用这些设备来更有效地管理心臟瓣膜状况。随后，医疗技术的快速进步以及透过提高精确度和护理来解决人口老化的复杂性的程序数量的增加将推动该产品在整个欧洲的普及。

产业生态系统分析
产业影响力
- 成长动力
  - 瓣膜性心臟病盛行率增加
  - 老年人口不断增加
  - 科技不断进步
- 产业陷阱与挑战
  - 球囊瓣膜成形术的局限性
  - 併发症的风险
成长潜力分析
技术景观
监管环境
未来市场趋势
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
主要市场参与者的竞争分析
竞争定位矩阵
战略展望矩阵

第 5 章：市场估计与预测：按产品类型，2021 - 2032

主要趋势
标准气球
切割气球
计分气球
高压气球
低压气球

第 6 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
主动脉瓣狭窄
肺动脉瓣狭窄

第 7 章：市场估计与预测：按年龄划分，2021 - 2032

主要趋势
儿科
成人

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
医院
门诊手术中心
专科诊所
其他最终用户

第 9 章：市场估计与预测：按地区划分，2021 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 10 章：公司简介

Abbott Laboratories
B. Braun Melsungen AG
Becton, Dickinson, and Company
Boston Scientific Corporation
Cardinal Health, Inc.
Cook Medical Inc.
Edwards Lifesciences Corporation
Innomed Medical Development Ltd.
Jotech GmbH
Medtronic plc
Microport Scientific Corporation
Numed Canada Inc.
NuMED Inc.
Osypka Medical GmbH
Teleflex Incorporated

简介目录

Product Code: 9540

Global Balloon Valvuloplasty Devices Market size is predicted to record 4.8% CAGR from 2024 to 2032, due to the rising healthcare expenditure and advancements in healthcare infrastructure. According to the American Medical Association, the healthcare spending in the U.S. increased by 4.1% in 2022 to $4.5 trillion or $13,493 per capita. This rise is supporting greater investment in advanced treatments for improved cardiac care.

Of late, significant resources are being allocated towards innovative treatments, including balloon valvuloplasty on account of the increasing healthcare expenditure. The expansion and enhancement of healthcare facilities are improving access to advanced procedures. In addition, the increasing investments in healthcare infrastructure is supporting the widespread use of balloon valvuloplasty devices, making them more accessible and effective in treating heart valve conditions.

The balloon valvuloplasty devices market is segregated into product type, application, age group, end-use, and region.

By product type, the cutting balloons segment is estimated to grow at a significant rate from 2024 to 2032, due to increasing demand to treat narrowed heart valves. These devices are making significant strides in improving cardiac care by offering a less invasive option compared to traditional surgical methods. Moreover, cutting balloons equipped with sharp blades have a prominent role in treating stenosis by making precise incisions in the valve's tissue which helps in widening the valve and restoring normal blood flow.

Balloon valvuloplasty devices industry from the ambulatory surgical centers end-use segment is expected to rise from 2024 to 2032, fueled by the increasing need for providing specialized care for patients with heart conditions. Balloon valvuloplasty devices are used in these centers to treat patients with narrowed heart valves. This technique allows minimally invasive procedures for improving patient outcomes and recovery times. By integrating these devices into their services, ambulatory surgical centers are ensuring that they are at the forefront of cardiac care for offering patients safer and more effective treatment options.

Regionally, the Europe balloon valvuloplasty devices industry size is anticipated to depict robust growth between 2024 and 2032, propelled by the aging population and the expansion of cardiovascular procedures. Healthcare providers in the region are adopting these devices to manage heart valve conditions more effectively. Subsequently, the rapid advancements in medical technology and the higher volume of procedures to address the complexities of the aging population with enhanced precision and care will drive the product uptake across Europe.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of valvular heart disease
  - 3.2.1.2 Rising geriatric population
  - 3.2.1.3 Growing technological advancements
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Limitations of balloon valvuloplasty
  - 3.2.2.2 Risk of complications
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Future market trends
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Standard balloon
5.3 Cutting balloon
5.4 Scoring balloon
5.5 High-pressure balloon
5.6 Low-pressure balloon

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Aortic valve stenosis
6.3 Pulmonary valve stenosis

Chapter 7 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Pediatric
7.3 Adult

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Ambulatory surgical centres
8.4 Specialty clinics
8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa